Home › Acute biphenotypische leukemie › Georgia › Atlanta
Acute biphenotypische leukemie klinische studies in Atlanta, GA
9 studies voor Acute biphenotypische leukemie zoeken deelnemers op locaties in en rond Atlanta (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruterenFase 1
- Emory University, Atlanta
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruterenFase 2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruterenFase 1/2
- Emory Winship Cancer Institute, Atlanta
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruterenFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruterenFase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
RekruterenFase 1
- Children's Healthcare of Atlanta, Atlanta
Venetoclax Basket Trial for High Risk Hematologic Malignancies
RekruterenFase 1
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
RekruterenFase 1
- Emory University - WINSHIP Cancer Center, Atlanta
- Emory University, Children's Healthcare of Atlanta, Atlanta
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruterenFase 1
- Children's Healthcare of Atlanta, Emory University, Atlanta
Acute biphenotypische leukemie studies in andere steden
- Seattle, WA15 studies
- Houston, TX11 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Memphis, TN7 studies
- Chicago, IL7 studies
- Charlotte, NC6 studies
- Aurora, CO6 studies
- Baldwin Park, CA6 studies
- Portland, OR6 studies
- Los Angeles, CA6 studies
- Philadelphia, PA6 studies
Andere studies in Atlanta
- Kanker (alle vormen)49 studies
- Niet-kleincellige longkanker47 studies
- Borstkanker41 studies
- Multipel myeloom41 studies
- Prostaatkanker33 studies
- Acute myeloïde leukemie30 studies
- Eierstokkanker29 studies
- Longkanker29 studies
- Colorectale kanker29 studies
- Metastatische kanker28 studies
- Hartfalen25 studies
- Ernstige depressieve stoornis25 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.